Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 182,002 - -
Change - -20.69% -0.18% 2.67% 11.05% -16.46% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 206,168 203,418 199,617
Change - -20.41% 0.28% 1.92% 9.66% -7.24% -1.33% -1.87%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 29.9x 23.1x 20.7x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.76x 3.6x 3.39x
PEG - -36.9x -2x 0x -0.7x -4.89x 0.8x 1.8x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.62x 3.33x 3.12x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 4.1x 3.72x 3.42x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 15.9x 14.1x 12.6x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 17.6x 15.6x 13.9x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 26x 21.7x 19.5x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.85% 4.6% 5.12%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.577 2.739 2.854
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.47% 2.62% 2.73%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.492 4.522 5.038
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 73.8% 60.6% 56.7%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,304 54,649 58,413
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,951 14,445 15,797
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,718 13,019 14,321
Net income 1 7,071 6,933 5,723 13,402 6,524 6,255 7,923 8,786
Net Debt 1 7,801 6,891 7,783 6,509 4,407 24,166 21,416 17,615
Reference price 2 140.74 109.79 110.07 113.11 125.29 104.49 104.49 104.49
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/22/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
19.11x3.34x11.74x3.53% 108B
17.31x0.19x12.22x0.76% 60.54B
31.19x7.57x19.79x1.28% 50.53B
39.6x3.14x10.7x2.42% 43.79B
38.06x1.39x12.2x0.26% 33.57B
29.82x5.34x17.02x-.--% 28.31B
38.63x6.76x24.22x0.27% 23.31B
24.05x3.51x12.63x1.21% 21.28B
19.85x2.74x10.67x1.59% 20.27B
Average 28.62x 3.78x 14.58x 1.26% 43.27B
Weighted average by Cap. 26.59x 3.54x 13.91x 1.72%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABTUS Stock
  5. Valuation Abbott Laboratories